ROCKET PHARMACEUTICALS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

ROCKET PHARMACEUTICALS, INC. reported Cash And Cash Equivalents At Carrying Value of $77.56 million for the year ending 2025.

  • ROCKET PHARMACEUTICALS, INC. showed a decrease of -52.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from ROCKET PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 13 years of available data (2013 to 2025), ROCKET PHARMACEUTICALS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 506.3%.
  • Historical annual values: Fiscal year 2025: $77.56 million | Fiscal year 2024: $163.64 million | Fiscal year 2023: $55.90 million | Fiscal year 2022: $140.52 million | Fiscal year 2021: $232.69 million | Fiscal year 2020: $297.10 million | Fiscal year 2019: $185.38 million | Fiscal year 2018: $111.36 million | Fiscal year 2017: $18.14 million | Fiscal year 2016: $29.80 million | Fiscal year 2015: $80.04 million | Fiscal year 2014: $3.62 million | Fiscal year 2013: $12.79 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: